DekaBank Deutsche Girozentrale - G1 THERAPEUTICS INC ownership

G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 115 filers reported holding G1 THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 1.16 and the average weighting 0.0%.

Quarter-by-quarter ownership
DekaBank Deutsche Girozentrale ownership history of G1 THERAPEUTICS INC
ValueSharesWeighting
Q3 2021$695,000
-34.7%
46,9000.0%0.00%
-33.3%
Q2 2021$1,065,000
-0.8%
46,9000.0%0.00%
-25.0%
Q1 2021$1,074,000
+27.1%
46,9000.0%0.00%
+33.3%
Q4 2020$845,000
+463.3%
46,900
+263.6%
0.00%
+200.0%
Q3 2020$150,000
-74.4%
12,900
-31.4%
0.00%
-66.7%
Q2 2019$585,000
-15.3%
18,800
+63.5%
0.00%
-25.0%
Q1 2019$691,000
+283.9%
11,500
+22.3%
0.00%
+300.0%
Q4 2018$180,000
-74.0%
9,400
-18.3%
0.00%
-75.0%
Q3 2018$691,000
+37.1%
11,500
-2.5%
0.00%
+33.3%
Q2 2018$504,000
+19.1%
11,8000.0%0.00%0.0%
Q1 2018$423,00011,8000.00%
Other shareholders
G1 THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Birchview Capital, LP 120,000$172,8000.15%
DENALI ADVISORS LLC 148,800$214,2720.08%
XTX Topco Ltd 296,601$427,1050.07%
NEEDHAM INVESTMENT MANAGEMENT LLC 234,000$336,9600.06%
LEVEL FOUR ADVISORY SERVICES, LLC 183,400$264,0960.02%
Curi Wealth Management, LLC 70,742$101,8690.02%
FRANKLIN STREET ADVISORS INC /NC 83,400$1200.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 140,000$201,6000.01%
JACOBS LEVY EQUITY MANAGEMENT, INC 573,256$825,4890.01%
ALGERT GLOBAL LLC 68,100$980.01%
View complete list of G1 THERAPEUTICS INC shareholders